Hypoxia-Mimicking Agents for Epithelial Stem Cell Preservation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions for preserving the functionality of epithelial stem cells, particularly in maintaining or stimulating hair and skin keratin material growth, density, and renewal, which is crucial for addressing conditions like alopecia and skin aging.
Innovation Solution
A process is developed to evaluate active agents that mimic a hypoxic state in keratin materials by increasing the expression of carbonic anhydrase IX, a biological marker of hypoxia, under normoxic conditions, using active agents that inhibit prolyl hydroxylase to stabilize HIF-1 protein, thereby mimicking the effects of a hypoxic microenvironment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to maintain epithelial stem cell functionality, then current treatments are available, but they lack effectiveness in preserving stem cell functionality and combating aging
Solution Approach 1:
The patent changes the chemical parameter of oxygen concentration by using hypoxia-mimicking compounds that stabilize HIF-1α protein under normoxic conditions, effectively creating a hypoxic microenvironment that preserves epithelial stem cell functionality and combats aging without requiring actual hypoxic conditions
Solution Approach 2:
The patent introduces hypoxia-mimicking compounds as intermediary substances that mediate between the desired hypoxic effect and the actual normoxic environment, allowing HIF-1α stabilization and downstream gene expression without direct oxygen deprivation
2Reliability
If hypoxic conditions are applied directly, then stem cell functionality is preserved, but the complexity of maintaining actual hypoxic environments increases
Solution Approach 1:
The patent creates a biochemical copy of the hypoxic signal by using compounds that mimic hypoxia-induced HIF-1α stabilization, reproducing the protective effects of hypoxia without requiring actual hypoxic conditions or complex environmental control systems
Solution Approach 2:
The patent replaces the mechanical/physical system of maintaining actual hypoxic environments with a chemical system using hypoxia-mimicking compounds, eliminating the need for complex gas control infrastructure while achieving the same biological effect
3Adaptability or versatility
If prolyl hydroxylase is inhibited to stabilize HIF-1, then hypoxic effects are achieved under normoxic conditions, but the mechanism requires specific molecular targets
Solution Approach 1:
The patent utilizes the natural feedback mechanism of the HIF-1α degradation pathway, where inhibition of prolyl hydroxylase prevents HIF-1α degradation and leads to accumulated HIF-1α that translocates to the nucleus and activates downstream genes, creating a self-amplifying hypoxic response
Data Source
AI summary
The present invention relates to a process for evaluating in vitro at least one active agent capable of preserving the functionality of epithelial stem cells, in particular of maintaining or stimulating the growth and/or the density and/or the renewal of a keratin material, consisting in determining the ability of the active agent(s) to mimic a hypoxic state in the keratin material, the active agent(s) being capable of increasing the expression of at least carbonic anhydrase IX as biological marker of hypoxia, in the keratin material treated with the active agent(s) compared with the keratin material not treated with the active agent(s). It also relates to the use of such a process.